![Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-39335-7/MediaObjects/41598_2019_39335_Fig1_HTML.png)
Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports
![IJERPH | Free Full-Text | Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study IJERPH | Free Full-Text | Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study](https://pub.mdpi-res.com/ijerph/ijerph-19-15359/article_deploy/html/images/ijerph-19-15359-g001-550.jpg?1669012870)
IJERPH | Free Full-Text | Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study
![Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article](https://assets.cureus.com/uploads/figure/file/240628/article_show_eddc5180e7e811ebbe70b79f4b23b4ca-diagram.webp)
Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article
![JCM | Free Full-Text | The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis JCM | Free Full-Text | The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis](https://pub.mdpi-res.com/jcm/jcm-11-04096/article_deploy/html/images/jcm-11-04096-g001.png?1658400858)